Definitions PFS is defined as the time between the first day of treatment with any drug (sunitinib, pazopanib, etc.) and the date of radiological progressive disease (PD), clear clinical evidence of PD, or death. Patients who had not progressed at database closure will be censored at final follow-up. If the date of PD is unknown, the investigators will censor PFS at the last tumour assessment.